| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.25 | 7e-07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |